ENCOMPASS HEALTH CORP (EHC) Fundamental Analysis & Valuation
NYSE:EHC • US29261A1007
Current stock price
107.25 USD
-1.08 (-1%)
At close:
107.25 USD
0 (0%)
After Hours:
This EHC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. EHC Profitability Analysis
1.1 Basic Checks
- EHC had positive earnings in the past year.
- In the past year EHC had a positive cash flow from operations.
- EHC had positive earnings in each of the past 5 years.
- In the past 5 years EHC always reported a positive cash flow from operatings.
1.2 Ratios
- EHC has a better Return On Assets (7.97%) than 92.00% of its industry peers.
- EHC has a better Return On Equity (23.16%) than 91.00% of its industry peers.
- EHC has a better Return On Invested Capital (13.45%) than 91.00% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for EHC is above the industry average of 8.51%.
- The last Return On Invested Capital (13.45%) for EHC is above the 3 year average (12.10%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.97% | ||
| ROE | 23.16% | ||
| ROIC | 13.45% |
ROA(3y)6.87%
ROA(5y)6.28%
ROE(3y)22.1%
ROE(5y)21.67%
ROIC(3y)12.1%
ROIC(5y)10.97%
1.3 Margins
- Looking at the Profit Margin, with a value of 9.51%, EHC belongs to the top of the industry, outperforming 96.00% of the companies in the same industry.
- In the last couple of years the Profit Margin of EHC has grown nicely.
- EHC's Operating Margin of 17.74% is amongst the best of the industry. EHC outperforms 96.00% of its industry peers.
- In the last couple of years the Operating Margin of EHC has grown nicely.
- The Gross Margin of EHC (95.71%) is better than 100.00% of its industry peers.
- EHC's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 17.74% | ||
| PM (TTM) | 9.51% | ||
| GM | 95.71% |
OM growth 3Y6.98%
OM growth 5Y3.59%
PM growth 3Y15.32%
PM growth 5Y3.68%
GM growth 3Y0.13%
GM growth 5Y0.11%
2. EHC Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so EHC is still creating some value.
- EHC has less shares outstanding than it did 1 year ago.
- EHC has more shares outstanding than it did 5 years ago.
- EHC has a better debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 2.97 indicates that EHC is not a great score, but indicates only limited risk for bankruptcy at the moment.
- With a decent Altman-Z score value of 2.97, EHC is doing good in the industry, outperforming 67.00% of the companies in the same industry.
- EHC has a debt to FCF ratio of 5.67. This is a neutral value as EHC would need 5.67 years to pay back of all of its debts.
- EHC has a Debt to FCF ratio of 5.67. This is comparable to the rest of the industry: EHC outperforms 54.00% of its industry peers.
- A Debt/Equity ratio of 1.00 is on the high side and indicates that EHC has dependencies on debt financing.
- Looking at the Debt to Equity ratio, with a value of 1.00, EHC is doing worse than 62.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1 | ||
| Debt/FCF | 5.67 | ||
| Altman-Z | 2.97 |
ROIC/WACC1.57
WACC8.55%
2.3 Liquidity
- A Current Ratio of 1.08 indicates that EHC should not have too much problems paying its short term obligations.
- EHC has a worse Current ratio (1.08) than 63.00% of its industry peers.
- EHC has a Quick Ratio of 1.08. This is a normal value and indicates that EHC is financially healthy and should not expect problems in meeting its short term obligations.
- The Quick ratio of EHC (1.08) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.08 | ||
| Quick Ratio | 1.08 |
3. EHC Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an impressive 23.25% over the past year.
- The Earnings Per Share has been growing by 13.57% on average over the past years. This is quite good.
- Looking at the last year, EHC shows a quite strong growth in Revenue. The Revenue has grown by 10.46% in the last year.
- EHC shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.72% yearly.
EPS 1Y (TTM)23.25%
EPS 3Y16.99%
EPS 5Y13.57%
EPS Q2Q%24.79%
Revenue 1Y (TTM)10.46%
Revenue growth 3Y10.92%
Revenue growth 5Y10.72%
Sales Q2Q%9.94%
3.2 Future
- EHC is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.21% yearly.
- EHC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.55% yearly.
EPS Next Y10.21%
EPS Next 2Y9.42%
EPS Next 3Y9.86%
EPS Next 5Y9.21%
Revenue Next Year8.29%
Revenue Next 2Y8.22%
Revenue Next 3Y8.06%
Revenue Next 5Y7.55%
3.3 Evolution
- The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. EHC Valuation Analysis
4.1 Price/Earnings Ratio
- EHC is valuated rather expensively with a Price/Earnings ratio of 19.64.
- 67.00% of the companies in the same industry are more expensive than EHC, based on the Price/Earnings ratio.
- When comparing the Price/Earnings ratio of EHC to the average of the S&P500 Index (26.86), we can say EHC is valued slightly cheaper.
- EHC is valuated rather expensively with a Price/Forward Earnings ratio of 17.82.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of EHC indicates a somewhat cheap valuation: EHC is cheaper than 66.00% of the companies listed in the same industry.
- EHC is valuated cheaply when we compare the Price/Forward Earnings ratio to 37.39, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.64 | ||
| Fwd PE | 17.82 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, EHC is valued a bit cheaper than 74.00% of the companies in the same industry.
- EHC's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 24.28 | ||
| EV/EBITDA | 9.41 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- EHC has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.92
PEG (5Y)1.45
EPS Next 2Y9.42%
EPS Next 3Y9.86%
5. EHC Dividend Analysis
5.1 Amount
- EHC has a yearly dividend return of 0.70%, which is pretty low.
- Compared to an average industry Dividend Yield of 0.47, EHC pays a better dividend. On top of this EHC pays more dividend than 83.00% of the companies listed in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.82, EHC's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.7% |
5.2 History
- The dividend of EHC decreases each year by -8.92%.
- EHC has paid a dividend for at least 10 years, which is a reliable track record.
- The dividend of EHC decreased recently.
Dividend Growth(5Y)-8.92%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
- 12.59% of the earnings are spent on dividend by EHC. This is a low number and sustainable payout ratio.
DP12.59%
EPS Next 2Y9.42%
EPS Next 3Y9.86%
EHC Fundamentals: All Metrics, Ratios and Statistics
107.25
-1.08 (-1%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-05 2026-02-05/amc
Earnings (Next)04-30 2026-04-30/amc
Inst Owners101.8%
Inst Owner Change-0.02%
Ins Owners1.18%
Ins Owner Change-3.37%
Market Cap10.66B
Revenue(TTM)5.94B
Net Income(TTM)564.70M
Analysts87.5
Price Target144.07 (34.33%)
Short Float %3.6%
Short Ratio2.93
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.7% |
Yearly Dividend0.71
Dividend Growth(5Y)-8.92%
DP12.59%
Div Incr Years1
Div Non Decr Years1
Ex-Date04-01 2026-04-01 (0.19)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.65%
Min EPS beat(2)1.94%
Max EPS beat(2)11.35%
EPS beat(4)4
Avg EPS beat(4)10.51%
Min EPS beat(4)1.94%
Max EPS beat(4)14.64%
EPS beat(8)8
Avg EPS beat(8)11.26%
EPS beat(12)12
Avg EPS beat(12)13.85%
EPS beat(16)15
Avg EPS beat(16)10.67%
Revenue beat(2)0
Avg Revenue beat(2)-0.95%
Min Revenue beat(2)-1.17%
Max Revenue beat(2)-0.73%
Revenue beat(4)2
Avg Revenue beat(4)0.01%
Min Revenue beat(4)-1.17%
Max Revenue beat(4)1.16%
Revenue beat(8)5
Avg Revenue beat(8)0.32%
Revenue beat(12)8
Avg Revenue beat(12)0.34%
Revenue beat(16)10
Avg Revenue beat(16)-2.28%
PT rev (1m)0%
PT rev (3m)0.65%
EPS NQ rev (1m)-0.17%
EPS NQ rev (3m)0.04%
EPS NY rev (1m)-0.02%
EPS NY rev (3m)2.53%
Revenue NQ rev (1m)-0.25%
Revenue NQ rev (3m)-0.69%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)-0.43%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.64 | ||
| Fwd PE | 17.82 | ||
| P/S | 1.8 | ||
| P/FCF | 24.28 | ||
| P/OCF | 9.07 | ||
| P/B | 4.37 | ||
| P/tB | 13.13 | ||
| EV/EBITDA | 9.41 |
EPS(TTM)5.46
EY5.09%
EPS(NY)6.02
Fwd EY5.61%
FCF(TTM)4.42
FCFY4.12%
OCF(TTM)11.82
OCFY11.03%
SpS59.7
BVpS24.52
TBVpS8.17
PEG (NY)1.92
PEG (5Y)1.45
Graham Number54.89
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.97% | ||
| ROE | 23.16% | ||
| ROCE | 16.84% | ||
| ROIC | 13.45% | ||
| ROICexc | 13.7% | ||
| ROICexgc | 18.64% | ||
| OM | 17.74% | ||
| PM (TTM) | 9.51% | ||
| GM | 95.71% | ||
| FCFM | 7.4% |
ROA(3y)6.87%
ROA(5y)6.28%
ROE(3y)22.1%
ROE(5y)21.67%
ROIC(3y)12.1%
ROIC(5y)10.97%
ROICexc(3y)12.29%
ROICexc(5y)11.11%
ROICexgc(3y)17.03%
ROICexgc(5y)16.37%
ROCE(3y)15.15%
ROCE(5y)13.74%
ROICexgc growth 3Y8.96%
ROICexgc growth 5Y3.92%
ROICexc growth 3Y11.11%
ROICexc growth 5Y12.23%
OM growth 3Y6.98%
OM growth 5Y3.59%
PM growth 3Y15.32%
PM growth 5Y3.68%
GM growth 3Y0.13%
GM growth 5Y0.11%
F-Score9
Asset Turnover0.84
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1 | ||
| Debt/FCF | 5.67 | ||
| Debt/EBITDA | 1.77 | ||
| Cap/Depr | 224.58% | ||
| Cap/Sales | 12.41% | ||
| Interest Coverage | 7.91 | ||
| Cash Conversion | 85.13% | ||
| Profit Quality | 77.78% | ||
| Current Ratio | 1.08 | ||
| Quick Ratio | 1.08 | ||
| Altman-Z | 2.97 |
F-Score9
WACC8.55%
ROIC/WACC1.57
Cap/Depr(3y)217.31%
Cap/Depr(5y)221.3%
Cap/Sales(3y)12.17%
Cap/Sales(5y)12.73%
Profit Quality(3y)77.97%
Profit Quality(5y)63.82%
High Growth Momentum
Growth
EPS 1Y (TTM)23.25%
EPS 3Y16.99%
EPS 5Y13.57%
EPS Q2Q%24.79%
EPS Next Y10.21%
EPS Next 2Y9.42%
EPS Next 3Y9.86%
EPS Next 5Y9.21%
Revenue 1Y (TTM)10.46%
Revenue growth 3Y10.92%
Revenue growth 5Y10.72%
Sales Q2Q%9.94%
Revenue Next Year8.29%
Revenue Next 2Y8.22%
Revenue Next 3Y8.06%
Revenue Next 5Y7.55%
EBIT growth 1Y21.82%
EBIT growth 3Y18.67%
EBIT growth 5Y14.7%
EBIT Next Year42.87%
EBIT Next 3Y19.43%
EBIT Next 5YN/A
FCF growth 1Y21.9%
FCF growth 3Y53.39%
FCF growth 5Y8.18%
OCF growth 1Y17.23%
OCF growth 3Y18.54%
OCF growth 5Y10.78%
ENCOMPASS HEALTH CORP / EHC Fundamental Analysis FAQ
What is the fundamental rating for EHC stock?
ChartMill assigns a fundamental rating of 6 / 10 to EHC.
What is the valuation status for EHC stock?
ChartMill assigns a valuation rating of 4 / 10 to ENCOMPASS HEALTH CORP (EHC). This can be considered as Fairly Valued.
What is the profitability of EHC stock?
ENCOMPASS HEALTH CORP (EHC) has a profitability rating of 9 / 10.
How financially healthy is ENCOMPASS HEALTH CORP?
The financial health rating of ENCOMPASS HEALTH CORP (EHC) is 4 / 10.
Can you provide the expected EPS growth for EHC stock?
The Earnings per Share (EPS) of ENCOMPASS HEALTH CORP (EHC) is expected to grow by 10.21% in the next year.